Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
GAC Motor’s display of its globalization drive and the latest models at the North American International Auto Show ticked all the right boxes as the leading automotive manufacturer in China built up intimacy with international customers, dealers and business partners.
GAC put its best foot forward in reinforcing its ambitions of making cars for the world as it shed the light on its go–outbound campaign during the international auto exhibition in Detroit that concluded on January 25, 2015.
“After meticulous planning and careful studies, we start to create our own brands by adopting international standards,” said Wu Song, general manager of GAC Motor. “We are confident that GAC Motor can churn out world-class vehicles to compete in the international market.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7447151-gac-motors-detroit-auto-show/
Nearly 12 million men in the U.S. suffer from symptoms related to benign prostatic hyperplasia (BPH), an enlargement of the prostate that can cause issues such as frequent and weak urinary streams and sleep deprivation from getting up repeatedly during the night to urinate. Since traditional BPH therapies such as daily medications and more invasive or surgical procedures often result in unwanted side effects and complications, more than 54 percent of men who would benefit from treating their BPH choose not to do anything1. With today’s national introduction of the FDA-cleared Rezūm® System, NxThera provides urologists and their patients suffering from symptomatic BPH with a new, safe and effective minimally-invasive, office-based treatment option which improves quality of life and preserves sexual function2 – one of the main reasons many men choose to forego medications or more invasive procedures.
“Men suffering from BPH are constantly evaluating the trade-offs between maintaining their current declined quality of life or treating their BPH symptoms and possibly incurring long term side effects,” said Dr. Kia Michel, M.D., a urologist at Comprehensive Urology in Los Angeles who recently performed the procedure as part of a nationally televised segment on prostate health. “Of all the minimally-invasive BPH treatments I’ve performed, Rezūm is the most effective and most versatile treatment available to patients – and the results have been excellent.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7933151-nxthera-rezum-therapy/
Jaguar announced the three renowned actors to appear in “Rendezvous,” its 60-second television advertisement to debut during the second half of Super Bowl XLVIII, and revealed details of its largest-ever brand and product marketing campaign, called “British Badboys” which introduces the Jaguar F-TYPE Coupe (on sale spring, 2014). “Rendezvous” stars Sir Ben Kingsley, Tom Hiddleston and Mark Strong, and was filmed by Oscar-winning British director, Tom Hooper, in London. It is Jaguar’s first Super Bowl TV advertisement.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64994-jaguar-first-super-bowl-commercial-f-type
The Perelman School of Medicine at the University of Pennsylvania and the March of Dimes Foundation announce the launch of a new $10 million Prematurity Research Center here.
The March of Dimes will invest $10 million during the next five years to create a transdisciplinary center conducting team-based research, led by physicians and researchers at the Hospital of the University of Pennsylvania and The Children’s Hospital of Philadelphia, to discover the unknown causes of preterm birth and develop new strategies to prevent it. This March of Dimes Prematurity Research Center at the University of Pennsylvania is part of a “medical Manhattan Project” of five such centers in the United States created by the foundation since 2011.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/65164-march-of-dimes-march-for-babies-2014/
More than 46 million turkeys will be cooked this Thanksgiving holiday, according to the National Turkey Federation, but many families aren’t taking the specific actions needed to reduce their risk of foodborne illness. In an effort to help protect Americans from foodborne illness during the Thanksgiving season and throughout the year, the Ad Council is partnering with the U.S. Department of Agriculture (USDA)’s Food Safety and Inspection Service to launch new public service advertisements (PSAs) on behalf of their national Food Safe Families campaign.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7383451-usda-ad-council-launch-psas-help-families-protect-from-foodborne-illness-this-thanksgiving/
INRIX®, Inc., a global leader for transportation analytics, today released its 2015 Traffic Scorecard, a benchmark for governments and agencies in the U.S. and Europe to measure progress in improving urban mobility.
The report reveals the U.S. faces large challenges to solve congestion issues, fueled by continued economic and population growth, higher employment rates and declining gas prices. Cities that have experienced the most economic improvement during the past year are at highest risk for consequences related to worsened traffic conditions, including reduced productivity, higher emissions and increased stress levels. For example, Washington D.C., San Francisco, New York, Seattle and Boston all saw reduced unemployment rates bringing them below the national average of 5.3 percent for 2015.1 However, according to the INRIX Traffic Scorecard, congestion in those cities alone combined to waste 1.5 billion hours for daily car commuters last year. Nationwide, commuters spent a total of more than eight billion extra hours stuck in traffic, representing almost 50 hours per driver.
To view the multimedia release go to:
http://www.multivu.com/players/English/7775551-inrix-2015-traffic-scorecard/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Youth homelessness charity Centrepoint and promoters SO-UK have brought together some of the biggest names in UK Soul, Blues and R ‘n’ B for one night only at Indigo O2 on 17th April to help give homeless young people a future.
‘SO-UK: Centrepoint Sessions’ is a sublime evening of UK Soul starring much loved artists from the UK soul movement: Carl McIntosh and the Loose Ends Experience, Omar, Junior, Imaani, Terri Walker, Don-e, Natasha Watts, Maya Blu, Femi Fem, Ronnie Herel, Fitzroy Facey (Soul Survivors), Sammy Confunktion – all keeping the vibe alive till the early hours. Young people supported by Centrepoint will also be performing during the evening.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7463551-centrepoint-uk-soul-stars-gig-homeless/
LeBron James. Stephen Curry. The Goodyear Blimp. The Chosen One. The Unanimous MVP. The World Famous Icon.
Three undeniable greats with one common bond – all were “Akron Born.”
With the world’s greatest basketball players set to compete on the sport’s biggest stage, The Goodyear Tire & Rubber Company will celebrate their birthplace by getting the next generation of Akron greats off to a winning start.
To do this, Goodyear will honor babies born in Akron-area hospitals during the NBA Finals with a “Most Valuable Ride” care package consisting of a set of Goodyear tires, an “AkronBorn” onesie and a brand-new infant car seat.
Three Akron-based medical facilities – Summa Akron City Hospital, Cleveland Clinic Akron General and Akron Children’s Hospital – will “assist” the initiative and help deliver the care packages to families of newborns. The package builds on Goodyear’s recent Safe Mobility Project with Akron Children’s Hospital.
To view the multimedia release go to:
http://www.multivu.com/players/English/7833452-goodyear-celebrates-great-things-akron/
Society for Science & the Public (Society) today announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is the new title sponsor of the Science Talent Search. Selected through a competitive process that garnered interest from the nation’s leading companies and philanthropists, Regeneron will become only the third sponsor in 75 years of the nation’s oldest and most prestigious high school science competition.
The new sponsorship will be celebrated at a special event today at the American Museum of Natural History, which is known for its extensive science education program. The event will be hosted by astrophysicist Neil deGrasse Tyson, Ph.D., Frederick P. Rose director of the Hayden Planetarium at the American Museum of Natural History, and can be viewed via webcast at 9:00 a.m. EDT at http://edge.media-server.com/m/go/sciencetalentsearch.
Regeneron is committing $100 million to support the Science Talent Search and other Society programs through 2026 and will assume title sponsorship of the competition effectively immediately. As part of its commitment, Regeneron is nearly doubling the overall award distribution to $3.1 million annually, increasing the top award to $250,000, and doubling the awards for the top 300 young scientists and their schools to $2,000 each. During its history, the Science Talent Search has provided more than $25 million in awards to over 8,500 students and schools.
To view the multimedia release go to:
http://www.multivu.com/players/English/7846351-regeneron-science-talent-search/
Consumers looking to save on a new car or truck should do their shopping in August, according to the analysts at TrueCar, Inc. the negotiation-free car buying and selling platform. New car and truck prices during the past five years in August have averaged $29,296 – $169 lower than any other month.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7286951-truecar-august-is-the-best-time-to-buy-a-car/
